iPath Seasonal Natural Gas ETN
DCNG
New York Stock Exchange Arca- -
USD
- -
- -
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.- Sector
- Financial Services
- Industry
- Asset Management
- Address
- 50 Hudson Yards New York NY United States of America 10001
- IPO Date
- Apr 21, 2011
- Website
- barclaysinvestments.co.uk
- Similar Companies
- Business
- iPath Seasonal Natural Gas ETN (DCNG) is an exchange-traded note issued by Barclays Bank PLC that seeks to track the performance of the Barclays Natural Gas Seasonal Index, providing investors exposure to seasonal patterns in natural gas futures contracts, primarily the December contract with annual rolling in October. The ETN offers a cash payment at its scheduled maturity on April 18, 2041, based on the index level; it is an uncollateralized senior debt obligation of Barclays Bank PLC with no principal protection. Barclays Bank PLC, founded in 1690 and headquartered in London, United Kingdom, operates globally through its investment banking and capital markets divisions, issuing the iPath series of ETNs linked to commodities including energy, agriculture, and metals; the firm does not manufacture physical products but provides structured investment products via NYSE Arca-listed securities. The iPath Seasonal Natural Gas ETN focuses on the natural gas futures market segment, targeting investors seeking leveraged or targeted commodity exposure without direct futures trading; it serves institutional and retail investors in energy derivatives. No subsidiaries are directly associated with this specific ETN, though it falls under Barclays' broader iPath ETN platform managed through Barclays Bank PLC. Recent activity shows the ETN remains actively quoted with a market capitalization of approximately $500,000 and trading volume as of December 2025, reflecting ongoing market interest despite low liquidity; it exhibits a 52-week price range of $16.19 to $21.43. No major partnerships, acquisitions, funding rounds, new product launches, or strategic shifts specific to DCNG have been announced in the last 1-2 years, consistent with its status as a long-dated, passively tracking ETN product from Barclays. The issuer maintains the product amid broader Barclays iPath ETN operations without noted reorganizations or operational changes affecting this ticker.